$627,225,000 in Total Settlement Funds Available. See if you qualify!Find Out More

Revance Therapeutics, Inc. Settlement
(NASDAQ: RVNC)
Settlement

Claim Deadline: August 28, 2026

Settlement Fund: $17,000,000

Settlement Class

All persons or entities that purchased or acquired Revance Securities (defined below) during the period of February 29, 2024 through the close of the subject Merger on February 6, 2025, inclusive (the “Class Period”), including common stock (CUSIP: 761330109; ticker “RVNC”) and 1.75% fixed coupon Convertible Senior Unsecured Notes (CUSIP: 761330AB5).

Important Documents

Settlement Status

Preliminarily Approved

Class Period

February 29, 2024 - February 28, 2025

Settlement Hearing Date

August 10, 2026

Opt-Out Deadline

July 13, 2026

Claims Admin

A.B. Data, Ltd.
P.O. Box 173120
Milwaukee, WI 53217
+1 877-507-1390
[email protected]

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.